38 results
8-K
EX-99.2
LYEL
Lyell Immunopharma, Inc.
26 Jun 24
Regulation FD Disclosure
8:32am
rate and durability Dose Level 1 Recommended Phase 2 dose CAR T-cell pharmacokinetics De-escalation if required Assessment of T-cell phenotype
S-3
EX-1.2
LYEL
Lyell Immunopharma, Inc.
28 Feb 24
Shelf registration
7:49pm
taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except
S-3
EX-4.5
xiqs5ix3naljhwny 5f
28 Feb 24
Shelf registration
7:49pm
8-K
EX-99.1
5q75 h6lobh
11 Sep 23
Regulation FD Disclosure
9:16am
S-3ASR
EX-4.4
5he1oxmt0q2llhtdpsui
4 Aug 22
Automatic shelf registration
5:29pm
S-3ASR
EX-1.2
kf1lni4j88i7mp7igs8z
4 Aug 22
Automatic shelf registration
5:29pm
DEF 14A
w482ow4xubni
28 Apr 22
Definitive proxy
4:11pm
10-K
EX-10.16
mw4uc
29 Mar 22
Annual report
4:20pm
10-K
ixznfjwjb64
29 Mar 22
Annual report
4:20pm